Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:51am, Tuesday, 30'th Sep 2025
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Many pharma companies already made U.S. investment promises, says Citi's Geoff Meacham
04:50pm, Friday, 26'th Sep 2025
CNBC's “Closing Bell Overtime” team discusses President Trump's plan to impose a 100% tariff on “all any branded or patented Pharmaceutical Product” entering the U.S. with Geoff Meacham of Cit
Goldman Sachs Sees 4 Rate Cuts by Next Summer: 5 High-Yield Dividend Winners
10:11am, Friday, 26'th Sep 2025
Investors love dividend stocks because they offer a significant income stream and have massive total return potential.
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
10:01am, Friday, 26'th Sep 2025
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS
09:00am, Friday, 26'th Sep 2025
THOUSAND OAKS, Calif. , Sept. 26, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced a $650 million expansion of its U.S. manufacturing network, creating hundreds of new jobs.
Amgen: MariTide's Progress, Reassessment Of The Horizon Acquisition
06:10am, Thursday, 25'th Sep 2025
Amgen has not been a great performer in the last two years. Investors became and remain skeptical of MariTide's prospects in obesity, type 2 diabetes, and other related indications. I continue to see
Amgen: Imdelltra Could Be The Next Game Changer
10:17am, Wednesday, 24'th Sep 2025
Despite the political noise coming out of the White House over efforts to lower drug prices, Amgen Inc.'s oncology franchise has continued to deliver strong performance since the start of 2025. So, AM
Amgen (AMGN) Moves 3.5% Higher: Will This Strength Last?
11:26am, Monday, 22'nd Sep 2025
Amgen (AMGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Why Amgen (AMGN) is a Top Value Stock for the Long-Term
10:41am, Wednesday, 17'th Sep 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
AMGN vs. VKTX: Which Biotech Stock Is the Better Obesity Play?
02:01pm, Tuesday, 16'th Sep 2025
Amgen's MariTide and Viking's VK2735 show promise in obesity, but pipeline strength and performance set the two biotech players apart.
Amgen: Buy The Dip Opportunity
08:30am, Sunday, 14'th Sep 2025
Amgen offers a compelling value and income opportunity after a recent price dip, trading below historical valuation multiples. AMGN posted strong Q2 results with robust performance across its innovati
2 Healthcare Dividend Stocks to Buy and Hold
07:15am, Sunday, 14'th Sep 2025
Between labor-market data and potential interest-rate cuts, Wall Street has a lot on its plate right now. In an environment like this one, it can be helpful to invest in solid, dividend-paying stocks
US FDA to step up enforcement of pharma ads, sends enforcement letters
07:12pm, Tuesday, 09'th Sep 2025
The U.S. Food and Drug Administration will send out around 100 cease-and-desist enforcement notices and thousands of letters warning pharmaceutical companies that direct-to-consumer ads must comply wi
Amgen Inc. (AMGN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
11:41am, Tuesday, 09'th Sep 2025
Amgen Inc. (NASDAQ:AMGN ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 9:15 AM EDT Company Participants Peter Griffith - Executive VP & CFO Kave Niksefat - Senior Vice Pre
THOUSAND OAKS, Calif. and TOKYO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Amgen (NASDAQ:AMGN) and Kyowa Kirin Co., Ltd. (TSE:4151) today announced preliminary top-line results from the ASCEND study evaluati
